ANCA-associated diseases and lung carcinomas: a five-case series

Clin Nephrol. 2014 Feb;81(2):132-7. doi: 10.5414/CN107407.

Abstract

Microscopic polyangiitis, granulomatosis with polyangiitis, Churg-Strauss syndrome and focal necrotizing glomerulonephritis are severe systemic vasculitides associated with circulating antineutrophil cytoplasmic antibodies (ANCA). Several studies reported that some malignancies can develop in these patients during follow-up, but few studies have considered the association and role of pre-existing cancers, at least in a fraction of patients. Herein, we report five patients with ANCA-associated diseases who had associated lung carcinomas or were diagnosed within 2 years after vasculitis onset. We discuss the putative role of tumor antigen in driving the auto-immune response.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / complications*
  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / immunology
  • Adenocarcinoma / surgery
  • Adenocarcinoma of Lung
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / complications*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / therapy
  • Antibodies, Antineutrophil Cytoplasmic / blood
  • Antigens, Neoplasm / immunology
  • Biomarkers / blood
  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / surgery
  • Fatal Outcome
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lung Neoplasms / complications*
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / immunology
  • Lung Neoplasms / surgery
  • Male
  • Neoplasm Staging
  • Plasmapheresis
  • Pneumonectomy
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antigens, Neoplasm
  • Biomarkers
  • Immunosuppressive Agents